EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS127-12513 
Organism
Homo sapiens 
Tissue/cell
Macrophage 
Coordinate
chr16:89258850-89259780 
TF binding sites/motifs
Number: 40             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF13MA0657.1chr16:89259438-89259456TAGCCACGCCCCTTCCTC+6.14
KLF14MA0740.1chr16:89259324-89259338AGCCACGCCCCTTC+6.1
KLF14MA0740.1chr16:89259439-89259453AGCCACGCCCCTTC+6.1
KLF14MA0740.1chr16:89259496-89259510AGCCACGCCCCTTC+6.1
SP1MA0079.4chr16:89259302-89259317GTAACCCCGCCCCCT+6.29
SP1MA0079.4chr16:89258961-89258976CTAACCCCGCCCCCT+6.37
SP1MA0079.4chr16:89259075-89259090CTAACCCCGCCCCCT+6.37
SP1MA0079.4chr16:89259132-89259147CTAACCCCGCCCCCT+6.37
SP1MA0079.4chr16:89259189-89259204CTAACCCCGCCCCCT+6.37
SP1MA0079.4chr16:89259474-89259489CTAACCCCGCCCCCT+6.37
SP1MA0079.4chr16:89259586-89259601CAAACCCCGCCCCCT+6.49
SP1MA0079.4chr16:89259437-89259452CTAGCCACGCCCCTT+6.73
SP2MA0516.2chr16:89258960-89258977CCTAACCCCGCCCCCTC+6.25
SP2MA0516.2chr16:89259074-89259091CCTAACCCCGCCCCCTC+6.25
SP2MA0516.2chr16:89259131-89259148CCTAACCCCGCCCCCTC+6.25
SP2MA0516.2chr16:89259188-89259205CCTAACCCCGCCCCCTC+6.25
SP2MA0516.2chr16:89259473-89259490CCTAACCCCGCCCCCTC+6.25
SP2MA0516.2chr16:89259585-89259602GCAAACCCCGCCCCCTC+6.39
SP4MA0685.1chr16:89259322-89259339CCAGCCACGCCCCTTCC+6.32
SP4MA0685.1chr16:89259302-89259319GTAACCCCGCCCCCTCA+6.42
SP4MA0685.1chr16:89259586-89259603CAAACCCCGCCCCCTCG+6.49
SP4MA0685.1chr16:89259494-89259511CCAGCCACGCCCCTTCT+6.4
SP4MA0685.1chr16:89258961-89258978CTAACCCCGCCCCCTCA+6.62
SP4MA0685.1chr16:89259075-89259092CTAACCCCGCCCCCTCA+6.62
SP4MA0685.1chr16:89259132-89259149CTAACCCCGCCCCCTCA+6.62
SP4MA0685.1chr16:89259189-89259206CTAACCCCGCCCCCTCA+6.62
SP4MA0685.1chr16:89259474-89259491CTAACCCCGCCCCCTCA+6.62
SP4MA0685.1chr16:89259437-89259454CTAGCCACGCCCCTTCC+7.35
ZNF263MA0528.1chr16:89259507-89259528TTCTCCACTGCCGCCTCCTCC-6.12
ZNF263MA0528.1chr16:89258940-89258961CTCCCCAGCTCCGCCTCCTCC-6.56
ZNF263MA0528.1chr16:89258997-89259018CTCCCCAGCTCCGCCTCCTCC-6.56
ZNF263MA0528.1chr16:89259054-89259075CTCCCCAGCTCCGCCTCCTCC-6.56
ZNF263MA0528.1chr16:89259111-89259132CTCCCCAGCTCCGCCTCCTCC-6.56
ZNF263MA0528.1chr16:89259168-89259189CTCCCCAGCTCCGCCTCCTCC-6.56
ZNF263MA0528.1chr16:89259453-89259474CTCCCCAGCTCCGCCTCCTCC-6.56
ZNF263MA0528.1chr16:89259222-89259243TTCCTCCCCAGCTCCTCCTCC-6.59
ZNF263MA0528.1chr16:89259278-89259299TTCCTCCCCAGCTCCTCCTCC-6.59
ZNF263MA0528.1chr16:89259338-89259359CTCCCCAGTTCCACCTCCTCC-6
ZNF263MA0528.1chr16:89259225-89259246CTCCCCAGCTCCTCCTCCTCC-7.76
ZNF263MA0528.1chr16:89259281-89259302CTCCCCAGCTCCTCCTCCTCC-7.76
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_35786chr16:89256645-89259045HepG2
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr168925900089259423
Number: 1             
IDChromosomeStartEnd
GH16I089191chr168925764989260937
Enhancer Sequence
GGGTGAGTGA GCGCCCCGCC TCCACCTGGA CCCTCGGACC CTCGGACCCT CCTCCCCAGG 60
CCGTCCCCTG CTAACCAGCC ACGCCGCTTC CTCCCCAGCT CCGCCTCCTC CCTAACCCCG 120
CCCCCTCATT ACCAGCCACG CCGCTTCCTC CCCAGCTCCG CCTCCTCCCT AACCCCGCCC 180
CGTCATTACC AGCCACGCCG CTTCCTCCCC AGCTCCGCCT CCTCCCTAAC CCCGCCCCCT 240
CATTACCAGC CACGCCGCTT CCTCCCCAGC TCCGCCTCCT CCCTAACCCC GCCCCCTCAT 300
TACCAGCCTC GCCGCTTCCT CCCCAGCTCC GCCTCCTCCC TAACCCCGCC CCCTCATTAC 360
CAGCCTCGCC GCTTCCTCCC CAGCTCCTCC TCCTCCCTAA CCCCGCCCCT CAGTACCAGC 420
CACGCCGCTT CCTCCCCAGC TCCTCCTCCT CCGTAACCCC GCCCCCTCAG TACCAGCCAC 480
GCCCCTTCCT CCCCAGTTCC ACCTCCTCCG CAACACCACC CACTCATTAC CAGCCACGCC 540
GCTTCCACCC AACCCGCCCC CTGCTCGCCA ACCCCGCCCC CTCATTACTA GCCACGCCCC 600
TTCCTCCCCA GCTCCGCCTC CTCCCTAACC CCGCCCCCTC ATTACCAGCC ACGCCCCTTC 660
TCCACTGCCG CCTCCTCCCC AACACCACCC ACTCATTACC AGCCACGCCG CTTCCACCCA 720
ACCCGCCCCC TGCTCGCAAA CCCCGCCCCC TCGTTGCCAG CCACGCCTCT TCCCCAAGCC 780
GGCCTCTCCT TACCAGCCAA GCTCCCTCCT CCACAACCCG GCCCCCTCCT CCCTAACCTC 840
GCGGCTTCCT CCCCAACCCC GGCTCCTCCA TGCCAGACAC GCCCTTTCCC CAACTGCCGC 900
CCCCTCAACC CCACCCCTGC TTACCAGCCT 930